Your browser doesn't support javascript.
loading
Real-world use of carfilzomib combined with lenalidomide and dexamethasone in patients with multiple myeloma in Europe and Israel.
Leleu, Xavier; Katodritou, Eirini; Kuehr, Thomas; Terpos, Evangelos; Caers, Jo; Zambello, Renato; Brescianini, Alessandra; Liang, Tony; Wetten, Sally; Badelita, Sorina N.
Afiliação
  • Leleu X; Department of Haematology University Hospital Centre La Miletrie and Inserm Poitiers France.
  • Katodritou E; Department of Haematology Theagenio Cancer Hospital Thessaloniki Greece.
  • Kuehr T; Department of Internal Medicine IV Academic Teaching Hospital Wels-Grieskirchen Wels Austria.
  • Terpos E; Department of Clinical Therapeutics, School of Medicine National and Kapodistrian University of Athens Athens Greece.
  • Caers J; Department of Haematology Liège University Hospital Centre Liège Belgium.
  • Zambello R; Department of Medicine Haematology and Clinical Immunology Branch, University of Padua Padua Italy.
  • Brescianini A; Research and Development Department Amgen (Europe) GmbH Rotkreuz Switzerland.
  • Liang T; Department of Biostatistics Parexel International Taipei Taiwan.
  • Wetten S; Center for Observational Research Amgen Ltd Uxbridge UK.
  • Badelita SN; Department of Hematology Fundeni Clinical Institute Bucharest Romania.
EJHaem ; 4(1): 174-183, 2023 Feb.
Article em En | MEDLINE | ID: mdl-36819146
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Observational_studies Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Observational_studies Idioma: En Ano de publicação: 2023 Tipo de documento: Article